NCT05072015尚未招募不适用
Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- MDS UPDRS IV (Movement Disorder Society - Unified Parkin-son Disease Rating Scale) score improvement
研究概览
简要总结
Primary purpose: Fluctuations and dyskinesia evolution in Parkinson's disease patients, one year after initiation of deep brain stimulation, apomorphin pump or duodopa pump
Secundary purposes:
- Motor complications evolution at 6 months, 2 and 3 years
- MDS UPDRS III score at 6 months, 1, 2 and 3 years
- non motor complications evolution at 6 months, 1, 2 and 3 years
- cognition and psychiatric complications evolution at 6 months, 1, 2 and 3 years
- cutaneous and digestive complications at 6 months, 1, 2 and 3 years
- neuropathy occurrence at 6 months, 1, 2 and 3 years
- medical treatment and Levodopa equivalent dose modifications at 6 months, 1, 2 and 3 years
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
MDS UPDRS IV (Movement Disorder Society - Unified Parkin-son Disease Rating Scale) score improvement
时间窗: 1 year
Evaluate the evolution of motor fluctuations and dyskinesias at one year in patients. treated with one of the 3 TSLs (bilateral stimulation of the subthalamic nucleus, apomorphine pump and duodopa pump. the higher the score, the more the disease is installed
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius ImplantArthroplasty, Replacement, ShoulderGlenoid CavityOsteoarthritis of the ShoulderNCT03806881Materialise24
招募中
2 期
Atezolizumab After Chemo-radiotherapy for muscle-invasive bladder cancer Patients Not Eligible for Radical Cystectomy2024-512002-26-00Unicancer77
已完成
不适用
Cross-sectional study of second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC.Advanced lung cancerJPRN-UMIN000006393SAPPHIRE Executive committee750
已完成
不适用
Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical TrialsHip OsteoarthritisNCT05930067Canadian Radiostereometric Analysis Network82
Unknown
不适用
Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.OsteoporosisNCT05369013STADA, Spain188